Pharmaceutical / Drug Definition :
Inhibits reuptake of norepinephrine or serotonin at presynaptic neuron, thereby increasing levels of these neurotransmitters in brain. Also has sedative, anticholinergic, and mild peripheral vasodilatory properties.
In the United States, Amoxapine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Amoxapine.
Registrar Corp assists Amoxapine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Amoxapine (Amoxapine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Amoxapine (Amoxapine Suppliers)
- Processors Amoxapine
- Repackers Amoxapine
- Relabelers Amoxapine
- Exporters Amoxapine
- Importers Amoxapine
For more information about Amoxapine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.